research publications

University of Sheffield

2003/4

Birtwhistle, B. and Hancock, B.W. (2003)
Hodgkin lymphoma.
Lymphoma Associations Newsletter 54 and website www.lymphoma.org.uk

Brown, J.E. and Coleman, R.E. (2003)
Metastatic Bone Disease. Developing Strategies to optimize management.
Therapy in Practice
American Journal of Cancer 2(4), 269-281.

Catto, J.W.F., Azzouzi, A.-R., Amira, N., Rehman, I., Feeley, K.M., Cross, S.S., Fromont, G., Sibony, M., Hamdy, F.C., Cussenot, O. and Meuth, M. (2003)
Distinct patterns of microsatellite instability are seen in tumours of the urinary tract.
Oncogene, 22, 8699-8706

Catto, J.W.F., Xinarianos, G., Burton, J.L., Meuth, M. and Hamdy, F.C. (2003)
Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage and prognosis but not microsatellite instability
International Journal of Cancer, 105, 484-490.

Coleman, R.E. (2003)
Current and future status of adjuvant therapy for breast cancer.
Skeletal Complications of Malignancy.
Cancer Supplement, 97(3) 880 886.

Cross, N.A., Murray, A.K., Rennie, I.G., Ganesh, A. and Sisley, K. (2003)
Instablility of microsatellites is an infrequent event in uveal melanoma.
Melanoma Research 13, 435-440

Croucher, P., Jagdev, S. and Coleman, R.E. (2003)
The anti-tumor potential of zoledronic acid.
The Breast (Suppl 2), S30-S36.

Draper, J.S., Smith, K., Gokhale, P.J., Moore, H.D., Maltby, E., Johnson, J., Meisner, L., Zwaka, T.P., Thomson, J.A. and Andrews, P.W. (2003)
Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells.
Nature Biotechnology 22, 53-54.

Gillespie, A.M. and Hancock, B.W. (2003)
Placental site trophoblastic tumour.
In: Gestational Trophoblastic Disease. Eds. Hancock, B.W., Newlands,E.S., Berkowitz, R.S. and Cole, L.A. 329 336.
www.isstd.org

Hancock, B.W. (2003)
Gestational Trophoblastic Disease. 2nd Edition. (2003)
Eds. Hancock, B.W., Newlands, E.S., Berkowitz, R.S. and Cole, L.A.
Published on World Wide Web: www.isstd.org

Hancock, B.W. (2003)
Differences in management and treatment: a critical appraisal.
In: Gestational Trophoblastic Disease. 2nd Edition. Eds. Hancock, B.W., Newlands,E.S., Berkowitz, R.S. and Cole, L.A. 337 347.
www.isstd.org

Hancock, B.W. (2003)
Staging and classification of gestational trophoblastic disease.
Best Practice & Research Clinical Obstetrics and Gynaecology 17, 869 883.

Hansen Tengbjerg, L., Lundin, C., Spang-Thomsen, M., Norgard Peterson, L.N. and Helleday, T. (2003).
The role of RAD51 in etoposide (VP16) resistance in small cell lung cancer.
International Journal of Cancer 105(4), 472-479.

Helleday, T. (2003)
Pathways for mitotic homologous recombination in mammalian cells.
Mutation Research 532, 103-115

Hinz, J.M., Helleday, T. and Meuth, M. (2003)
Reduced apoptotic response to camptothecin in CHO cells deficient in XRCC3.
Carcinogenesis 24, 249-253.

Hough, R.E., Lorigan, P.C., Poynton, C., Newland, A., Gupta, R.K., Foran, J. and Hancock, B.W. (2003)
A phase II protection study of BB-10010 in patients with high grade non-Hodgkins lymphoma undergoing intensive chemotherapy.
International Journal of Oncology 22, 421-424.

Low, S.E., Horsman, J.M., Walters, S.J., Hancock, H., Smith, P., Linch, D. and Hancock, B.W. (2003)
Risk-adjusted prognostic models for Hodgkins disease (HD) and grade II non-Hodgkins lymphoma (NHL II) : validation on 6728 British National Lymphoma Investigation patients.
British Journal of Haematology, 120, 277-280.

Lundin, C., Schultz, N., Arnaudeau, C., Mohindra, A., Tengbjerg Hansen, L. and Helleday, T. (2003)
RAD51 is involved in repair of damage associated with DNA replication in mammalian cells.
Journal of Molecular Biology 328, 521-535.

Musson, R., Radstone, C.R., Horsman, J.M., Hancock, H., Goepel, J.R. and Hancock, B.W. (2003)
Peripheral T cell lymphoma: The Sheffield Lymphoma Group experience (1977-2001).
International Journal of Oncology 22, 1363 1368

Newlands, E.S., Hancock, B.W., Cole, L.A. and Berkowitz, R.S. (2003)
Future prospects.
In: Gestational Trophoblastic Disease. Eds. Hancock, B.W., Newlands,E.S., Berkowitz, R.S. and Cole, L.A. 380 - 394.
http://www.ycr.org.uk/web/ycr/link_isstd.html

Rafii, S., Lindblom, A., Reed, M., Meuth, M. and Cox, A. (2003)
A naturally occurring mutation in an ATP-binding domain of the recombination repair gene XRCC3 ablates its function without causing cancer susceptibility.
Human Molecular Genetics 12, 915-923.

Schultz, N., Lopez, E., Saleh-Gohari, N., and Helleday, T. (2003)
Poly(ADP-ribose) Polymerase (PARP-1) has a controlling role in homologous recombination.
Nucleic Acids Research 31(17), 4959-4964.

Tham, B.W.L., Everard, J.E., Tidy, J.A., Drew, D. and Hancock, B.W. (2003)
Gestational trophoblastic disease in the Asian population of Northern England and North Wales.
British Journal of Obstetrics and Gynaecology, 110, 555-559.

Wheatley, K., Ives, N., Hancock, B. Gore, M., Eggermont, A. and Suciu, S. (2003)
Does adjuvant interferon-a for high-risk melanoma provide a worthwhile benefit? A meta-analysis of the randomised trials.
Cancer Treatment Reviews 29, 241-252.